Hence, TRIM71 may serve as a liver cancer-specific biomarker and RBP in regulating fetal-like phenotype and maintaining the survival advantage conferred by oncofetal reprogramming, which deserves further exploration. This evidence concerns the gene TRIM71 and liver cancer.